1. Home
  2. ZBIO
  3. ZBIO News

Latest ZENAS BIOPHARMA INC (ZBIO) News on January 22, 2025

Zenas BioPharma initiated with a Buy at H.C. Wainwright
ZBIO

TipRanks

a month ago

Zenas BioPharma initiated with a Buy at H.C. Wainwright

ZBIO

MT Newswires

a month ago

HC Wainwright Initiates Zenas BioPharma at Buy With $30 Price Target

Zenas BioPharma price target lowered to $35 from $40 at Morgan Stanley
ZBIO

TipRanks

a month ago

Zenas BioPharma price target lowered to $35 from $40 at Morgan Stanley

ZBIO

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 12/05/2024

ZBIO

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 11/21/2024

Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
ZBIO

GlobeNewswire

2 months ago

Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Zenas BioPharma Completes Targeted Enrollment of the Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)
ZBIO

GlobeNewswire

2 months ago

Zenas BioPharma Completes Targeted Enrollment of the Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences
ZBIO

GlobeNewswire

2 months ago

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences

Opening Day: Another trio of biotech IPOs make Friday debut
ZBIO

TipRanks

3 months ago

Opening Day: Another trio of biotech IPOs make Friday debut

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
ZBIO

GlobeNewswire

4 months ago

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

Share on Social Networks: